n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with myelin basic protein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Z; Han, Z; Kong, Q; Li, G; Li, H; Li, N; Liu, Y; Mu, L; Sun, B; Wang, G; Wang, J; Xie, X; Yu, B; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and myelin basic protein
| Article | Year |
|---|---|
Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms.
Topics: Animals; Autoantibodies; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Disease Models, Animal; Female; In Vitro Techniques; Ligands; Myasthenia Gravis, Autoimmune, Experimental; Myelin Basic Protein; Nerve Growth Factors; Nitrobenzenes; Peptide Fragments; Rats; Rats, Inbred Lew; Receptor for Advanced Glycation End Products; Receptors, Cholinergic; Receptors, Immunologic; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Sulfonamides; T-Lymphocyte Subsets; Up-Regulation | 2011 |